Skandinaviska Enskilda Banken (SEB)
BLUE

Skandinaviska Enskilda Banken (SEB)’s bluebird bio BLUE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,382
Closed -$342K – 1005
2021
Q3 		$342K Buy
+1,382
New +$395K ﹤0.01% 893
2020
Q3 		– Sell
-286
Closed -$226K – 1036
2020
Q2 		$226K Buy
+286
New +$216K ﹤0.01% 907

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s BLUE Position: Q4 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 1,382 shares — an estimated $342K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in BLUE in Q2 2020 and held it in 2 quarters. The position peaked at $342K in Q3 2021. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,382 bluebird bio shares in Q4 2021, an estimated $342K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in bluebird bio in Q2 2020 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s bluebird bio position peaked at $342K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2021, filed 10 Feb 2022.